Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/
我们正在追踪 Teva Pharmaceuticals 的市场扩张
最近 90 天内有 66 个信号。
Teva Pharmaceuticals 的国际扩张与竞争对手的对比情况
Teva Pharmaceuticals你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Teva Pharmaceuticals你 | 0 | 0 | — | 0 | 0 |
Quality Control Analyst I
查看职位Kfar Saba, Center District, Israel · 前天
Sr Director Supply Chain
查看职位Dupnitsa, Kyustendil, Bulgaria · 3天前
Manager, Category Excellence / Capability Lead ExM GP
查看职位Sofia, Sofia City, Bulgaria · 3天前
Today, we announced Teva Pharmaceuticals’ Q1 2026 financial results, marking a strong start to the year and reinforcing our transformation into a leading biopharma company.Our key innovative products are becoming an engine of sustainable growth, collectively growing 41% year-over-year in local currency and continuing to shift Teva’s portfolio mix. We also saw continued progress on our late-stage innovative pipeline and stable generics performance driven by biosimilars growth. That's what our Piv ...
进行中
Explore open roles at Teva India >>
进行中
This post is directed to HCPs only.Looking for expert perspectives on the evolving role of long-acting injectables (LAIs) in improving the lives of people living with schizophrenia?Come along to the Forum Hall at 13.15 on Sunday 29th March during EPA 2026 in Prague to hear from an expert faculty as they consider the evolving evidence, opinion and guidelines supporting the wider integration of LAIs into clinical practice.13.15-14.15, Forum Hall (second floor)https://lnkd.in/eqRnEUpf Please do n ...
已结束特拉维夫证券交易所上涨，Tower Semiconductor和Teva领涨。以色列联合银行在高成交量下下跌。
梯瓦制药在连续三年增长后，预计2026年收入和利润将下降，预期收入为164-168亿美元，每股收益为2.55-2.65美元。
Teva制药的API部门将在两年内于以色列裁减250个职位,作为运营调整的一部分,主要影响贝尔谢巴附近的Neot Hovav工厂。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Teva Pharmaceuticals 的业务、市场和增长信号的快速解答。
